DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Micropro Software Solutions Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·14 Oct 2026, 10:54 am

Micropro Software Solutions

Micropro Software Solutions Ltd filed a notice with the stock exchange stating that it has obtained a certificate under SEBI (Depositories and Participants) Regulations, 2018. This certificate confirms that the company’s depository participants comply with SEBI’s rules on securities holding, transfer and settlement.

For investors, the filing signals that the company is meeting regulatory requirements, which helps ensure smooth clearing and settlement of its shares and reduces the risk of compliance‑related disruptions. It does not directly affect the company’s financial performance but is a standard compliance disclosure.

Investors should watch for any subsequent filings that may detail changes in shareholding patterns, dematerialisation status, or further regulatory updates that could affect the trading of Micropro’s shares.